In patients with type 2 diabetes (T2D), dual therapy with metformin and GLP-1 receptor agonists (RAs) was associated with a 39% lower risk for adiposity-related cancers and a 67% lower risk for ...
With buzzy medications like Ozempic and Mounjaro making headlines for blood sugar management, it’s easy to forget that some medications have been helping patients with type 2 diabetes for decades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback